Krystal Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5011471027
USD
254.95
4.87 (1.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
107.11
97.80
96.04
88.18
91.14
83.84
70.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
107.11
97.80
96.04
88.18
91.14
83.84
70.28
Raw Material Cost
8.15
5.66
8.71
6.66
6.54
8.17
8.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
41.45
37.58
33.62
31.09
29.70
27.23
25.64
Other Expenses
1.32
1.32
1.44
1.43
1.35
1.35
1.56
Total Expenditure (Excl Depreciation)
62.83
56.43
56.73
52.01
49.76
48.91
49.22
Operating Profit (PBDIT) excl Other Income
44.3
41.4
39.300000000000004
36.2
41.4
34.900000000000006
21.099999999999998
Other Income
6.86
6.59
7.47
7.42
7.23
7.34
7.48
Operating Profit (PBDIT)
52.89
49.58
48.32
45.23
50.20
43.76
30.53
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-12.50
-12.50
Gross Profit (PBDT)
98.95
92.14
87.33
81.52
84.60
75.67
62.29
Depreciation
1.76
1.61
1.54
1.63
1.59
1.49
1.99
Profit Before Tax
51.13
47.97
46.77
43.60
48.61
29.77
16.05
Tax
-0.27
-31.40
8.44
7.86
3.13
2.59
0.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.40
79.36
38.33
35.73
45.48
27.18
15.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.40
79.36
38.33
35.73
45.48
27.18
15.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.40
79.36
38.33
35.73
45.48
27.18
15.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,219.56
1,137.88
1,040.65
984.67
946.38
885.85
838.89
Earnings per share (EPS)
1.7
2.66
1.29
1.2
1.52
0.91
0.53
Diluted Earnings per share
1.7
2.66
1.29
1.2
1.52
0.91
0.53
Operating Profit Margin (Excl OI)
41.33%
42.3%
40.93%
41.02%
45.4%
41.67%
29.97%
Gross Profit Margin
49.38%
50.69%
50.31%
51.29%
55.08%
37.28%
25.65%
PAT Margin
47.99%
81.15%
39.91%
40.52%
49.9%
32.42%
22.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 17.56% vs 116.39% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 12.97% vs 422.99% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 6.98% vs 834.78% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Krystal Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
107.11
196.00
-88.89
-45.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
107.11
196.00
-88.89
-45.35%
Raw Material Cost
8.15
14.60
-6.45
-44.18%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
3.21
-3.21
-100.00%
Selling and Distribution Expenses
41.45
168.74
-127.29
-75.44%
Other Expenses
1.32
4.55
-3.23
-70.99%
Total Expenditure (Excl Depreciation)
62.83
232.02
-169.19
-72.92%
Operating Profit (PBDIT) excl Other Income
44.27
-36.03
80.30
222.87%
Other Income
6.86
2.04
4.82
236.27%
Operating Profit (PBDIT)
52.89
-31.71
84.60
266.79%
Interest
0.00
3.21
-3.21
-100.00%
Exceptional Items
0.00
9.07
-9.07
-100.00%
Gross Profit (PBDT)
98.95
181.40
-82.45
-45.45%
Depreciation
1.76
2.27
-0.51
-22.47%
Profit Before Tax
51.13
-28.13
79.26
281.76%
Tax
-0.27
0.43
-0.70
-162.79%
Provisions and contingencies
0
0
0.00
Profit After Tax
51.40
-28.56
79.96
279.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
51.40
-28.56
79.96
279.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.40
-28.56
79.96
279.97%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,219.56
88.30
1,131.26
1,281.16%
Earnings per share (EPS)
1.70
-0.56
2.26
403.57%
Diluted Earnings per share
1.70
-0.56
2.26
403.57%
Operating Profit Margin (Excl OI)
41.33%
-18.38%
0.00
59.71%
Gross Profit Margin
49.38%
-13.19%
0.00
62.57%
PAT Margin
47.99%
-14.57%
0.00
62.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10.71 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.51% vs 1.87% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 17.56% vs 116.39% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.14 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -35.26% vs 107.31% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.97% vs 422.99% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.98% vs 5.13% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 6.98% vs 834.78% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.33%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024